<DOC>
	<DOC>NCT01133392</DOC>
	<brief_summary>This study will compare how the body treats 2 different forms of insulin lispro and how they affect blood sugar levels.</brief_summary>
	<brief_title>Bioequivalence of Two Lispro Formulations</brief_title>
	<detailed_description>The 2 formulations of insulin lispro will be referred to here as: Lispro A Lispro B</detailed_description>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Are healthy males or females. Body mass index (BMI) between 18.5 and 29.9 kilograms per meter squared (kg/m^2) Are nonsmokers. Have normal blood pressure and pulse rate, a normal electrocardiogram (ECG), and clinical laboratory test results within normal reference range at screening. History of firstdegree relatives known to have diabetes mellitus. Evidence of significant active neuropsychiatric disease. Evidence of an acute infection with fever or infectious disease. Intend to use overthecounter or prescription medication (apart from vitamin/mineral supplements, occasional paracetamol, or birth control methods). Have used systemic glucocorticoids within 3 months prior to entry into the study. Have donated blood of 1 unit or more within the last 3 months prior to study entry. Excessive alcohol intake Have a fasting venous blood glucose (FBG, plasma) &gt;6 millimoles/liter (mmol/L) at screening. Have positive hepatitis B surface antigen.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>insulin</keyword>
	<keyword>lispro</keyword>
</DOC>